IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Bafna Pharmaceuticals IPO is a Fixed Price IPO listing on BSE,NSE exchange, with an ipo size of ₹ 25.60 Cr. The company is based in Chennai and caters to Pharmaceutical sector. Keynote Financial Services , Ashika Capital are the merchant bankers of Bafna Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th December 2007. Bafna Pharmaceuticals IPO open date is 27th May 2008 and close date is 30th May 2008. IPO Allotment Date is 30th November -0001 and Listing date is 27th June 2008.
IPO
Size:
₹ 25.60 Cr.
Avg IPO Size (Sector Based)
: ₹
1,326.67 cr.
Sector: Pharmaceutical
IPO so far:
25
Merchant Banker:
Keynote Financial
IPO by BRLM so far:
17
City:
Chennai
IPO so far:
39
Revenue (annualised):
₹
17.28
cr. 
PE
Ratio:
12.44x
Average Sector PE Ratio: 27.74x
Bafna Pharmaceuticals IPO size is ₹ 25.60 Cr. with IPO price of ₹ 40.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Keynote Financial Services Limited is the book-running lead manager of the Bafna Pharmaceuticals IPO. Cameo Corporate Services Limited is the Registrar for Bafna Pharmaceuticals IPO.
Bafna Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Bafna Pharmaceuticals IPO, based in Chennai, operates in the Pharmaceutical sector with a focus on pharmaceutical. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Fixed Price Issue method. Bafna Pharmaceuticals IPO size is ₹ 25.60 Cr. with fresh issue size of ₹ 26 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Bafna Pharmaceuticals IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Bafna Pharmaceuticals IPO allotment status on the registrars website, Cameo Corporate Services Limited . Bafna Pharmaceuticals IPO refund dates are 30th November -0001.
Bafna Pharmaceuticals IPO is expected to be listed on 27th June 2008.
The upper price band for the Bafna Pharmaceuticals IPO is set at ₹ 40.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Bafna Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Bafna Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 30th May 2008. After submission, funds are blocked until the basis of allotment of Bafna Pharmaceuticals IPO is finalised.
The merchant banker for Bafna Pharmaceuticals IPO is Keynote Financial Services Limited , Ashika Capital Limited . Keynote Financial Services Limited , Ashika Capital Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Bafna Pharmaceuticals IPO RHP for further details.
The registrar for Bafna Pharmaceuticals IPO is Cameo Corporate Services Limited . Investors can go to Cameo Corporate Services Limited registrar website for IPO allotment status, refund processing, and other queries related to Bafna Pharmaceuticals IPO through their official website or helpline.
Bafna Pharmaceuticals IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
₹ 25.60 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,326.67 Cr.
Sector: Pharmaceutical
IPO so far:
25
Merchant Banker:
Keynote Financial
IPO by BRLM so far:
17
City:
Chennai
IPO so far:
39
Revenue (annualised):
₹ 32.91 cr.
PE
Ratio:
12.44x
Average Sector PE Ratio: 27.74x
Bafna Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Bafna Pharmaceuticals Financial Review Page
Merchant Banker(s) of Bafna Pharmaceuticals IPO: Keynote Financial Services Limited , Ashika Capital Limited
Bafna Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bafna Pharmaceuticals IPO listed at a listing price of 38.50 against the offer price of 40.00.
The current market price of Bafna Pharmaceuticals is .
Why Us?
